| Active substance |
Hyaluronic acid |
| Also known as |
Sodium hyaluronate, hyaluronan |
| Blood pressure |
No direct effects |
| Chemical name |
Hyaluronic acid |
| Dosage (medical) |
Varies by treatment type, commonly 20 to 30 mg for intra-articular injections |
| Dosage (sports) |
Not typically used for performance enhancement |
| Effects |
Increased skin hydration, improved wound healing, pain relief in osteoarthritis |
| FORM |
1 syringe x 4 ml x 80 mg |
| Formula |
(C14H21NO11)n |
| Half-life |
2 to 5 minutes in the bloodstream, up to several days in tissues |
| Hepatotoxicity |
None reported |
| Lab Test |
Viscosity and molecular weight analysis |
| Main action |
Moisturizing and healing |
| Side effects |
Pain at injection site, allergic reactions, swelling |
| Storage conditions |
Store at 2-8В°C, away from light |
| Substance class |
Glycosaminoglycan |
| Trade name |
Hyalgan, Synvisc, Juvederm |
| Use in sports |
Primarily in recovery and treatment of joint disorders |
| Water Retention |
High |
| Manufacturer |
Aptissen |
